Teladoc Health [TDOC] vs Certara [CERT] Detailed Stock Comparison

Teladoc Health Inc.

NYSE
Loading...

Certara Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Teladoc Health Inc. wins in 9 metrics, Certara Inc. wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Teladoc Health Inc. Certara Inc. Better
P/E Ratio (TTM) N/A 105.00 N/A
Price-to-Book Ratio 0.74 0.95 Teladoc Health Inc.
Debt-to-Equity Ratio 75.06 28.96 Certara Inc.
PEG Ratio -6.16 -0.53 Certara Inc.
EV/EBITDA 38.86 11.42 Certara Inc.
Profit Margin (TTM) -7.92% -0.38% Certara Inc.
Operating Margin (TTM) -4.20% 2.08% Certara Inc.
EBITDA Margin (TTM) N/A 2.08% N/A
Return on Equity -13.93% -0.15% Certara Inc.
Return on Assets (TTM) -3.20% 0.93% Certara Inc.
Free Cash Flow (TTM) $137.33M $69.77M Teladoc Health Inc.
1-Year Return 7.00% -52.77% Teladoc Health Inc.
Price-to-Sales Ratio (TTM) 0.41 2.31 Teladoc Health Inc.
Enterprise Value $1.28B $1.12B Teladoc Health Inc.
EV/Revenue Ratio 0.51 2.68 Teladoc Health Inc.
Gross Profit Margin (TTM) 69.32% 62.21% Teladoc Health Inc.
Revenue per Share (TTM) $14 $3 Teladoc Health Inc.
Earnings per Share (Diluted) $-34.20 $-0.01 Certara Inc.
Beta (Stock Volatility) 2.08 1.62 Certara Inc.
Short % of Float 16.55% 22.71% Teladoc Health Inc.

Teladoc Health Inc. vs Certara Inc. Stock Performance Analysis

Loading Price Chart...

TDOC
CERT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Teladoc Health Inc.1.63%5.37%17.30%38.40%1.63%5.82%
Certara Inc.0.19%-0.19%16.29%-19.72%-40.39%-40.39%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Teladoc Health Inc.7.00%-70.52%-95.30%-42.92%-73.79%-73.79%
Certara Inc.-52.77%-70.03%-81.17%-86.34%-86.34%-86.34%

Performance & Financial Health Analysis: Teladoc Health Inc. vs Certara Inc.

MetricTDOCCERT
Market Information
Market Cap i$1.04B$969.01M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,716,7502,754,263
90 Day Avg. Volume i4,439,2774,134,951
Last Close$7.46$5.21
52 Week Range$4.40 - $9.77$4.45 - $13.88
% from 52W High-23.64%-62.46%
All-Time High$308.00 (Feb 15, 2021)$45.48 (Nov 01, 2021)
% from All-Time High-97.58%-88.54%
Growth Metrics
Quarterly Revenue Growth0.00%0.03%
Quarterly Earnings Growth0.00%0.03%
Financial Health
Profit Margin (TTM) i-0.08%0.00%
Operating Margin (TTM) i-0.04%0.02%
Return on Equity (TTM) i-0.14%0.00%
Debt to Equity (MRQ) i75.0628.96
Cash & Liquidity
Book Value per Share (MRQ)$7.77$6.68
Cash per Share (MRQ)$4.38$1.19
Operating Cash Flow (TTM) i$294.36M$96.33M
Levered Free Cash Flow (TTM) i$226.14M$96.40M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Teladoc Health Inc. vs Certara Inc.

MetricTDOC (Apr 26, 2026)CERT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A105.00
Forward P/E i-6.1612.87
PEG Ratio i-6.16-0.53
Price to Sales (TTM) i0.412.31
Price to Book (MRQ) i0.740.95
Market Capitalization
Market Capitalization i$1.04B$969.01M
Enterprise Value i$1.28B$1.12B
Enterprise Value Metrics
Enterprise to Revenue i0.512.68
Enterprise to EBITDA i38.8611.42
Risk & Other Metrics
Beta i2.081.62
Book Value per Share (MRQ) i$7.77$6.68

Financial Statements Comparison: Teladoc Health Inc. vs Certara Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTDOC (2025)CERT (2025)
Revenue/Sales i2.53B418.84M
Cost of Goods Sold i771.59M161.13M
COGS % of Revenue i30.5%38.5%
Gross Profit i1.76B257.71M
Gross Margin i69.5%61.5%
Research & Development i277.92M41.04M
Operating Income (EBIT) i-163.40M21.02M
Operating Margin i-6.5%5.0%
EBITDA i260.18M102.52M
EBITDA Margin i10.3%24.5%
Pre-Tax Income i-235.53M7.62M
Pre-Tax Income % of Revenue i-9.3%1.8%
Income Tax i-35.21M9.21M
Income Tax % of Revenue i-1.4%2.2%
Net Income (Profit) i-200.32M-1.60M
Profit Margin i-7.9%-0.4%

Balance Sheet & Liquidity Metrics

MetricTDOC (2025)CERT (2025)
Cash & Equivalents i781.08M189.39M
Total Current Assets i1.12B315.12M
Total Current Assets % of Revenue i44.2%75.2%
Total Current Liabilities i404.74M153.39M
Total Current Liabilities % of Revenue i16.0%36.6%
Long-Term Debt i1.03B298.57M
Long-Term Debt % of Revenue i40.7%71.3%
Total Shareholders Equity i1.39B1.06B
Retained Earnings i-16.43B-129.88M
Retained Earnings % of Revenue i-649.4%-31.0%
Property, Plant & Equipment i42.03M11.94M

Cash Flow Statement Comparison

MetricTDOC (2025)CERT (2025)
Operating Cash Flow i225.59M91.68M
Operating Cash Flow % of Revenue i8.9%21.9%
Capital Expenditures iN/AN/A
Free Cash Flow i137.33M69.77M
FCF Margin i5.4%16.7%
Debt Repayment i-550.63M-2.99M
Common Stock Repurchase iN/A-42.61M

Short Interest & Institutional Ownership Analysis

MetricTDOCCERT
Shares Short i29.71M22.29M
Short Ratio i6.895.09
Short % of Float i16.55%22.71%
Shares Outstanding i178.32M159.14M
Float Shares i176.23M109.20M
% Held by Insiders i0.65%2.50%
% Held by Institutions i75.86%116.00%
% Held by Public i23.49%-18.50%

Dividend Analysis & Yield Comparison: Teladoc Health Inc. vs Certara Inc.

MetricTDOCCERT
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A